Skip to main content
. Author manuscript; available in PMC: 2015 Aug 14.
Published in final edited form as: Chem Commun (Camb). 2014 Jun 25;50(63):8739–8742. doi: 10.1039/c4cc03909b

Figure 5.

Figure 5

Treatment of MDA-MB-468cells with γ-AApeptides decreases the levels of survivin and cyclin D1 but not P-STAT3. MDA-MB-468 cells were treated overnight with 100 μM compounds and processed for western immunoblotting with the indicated antibodies as described in Methods. S3I-1757 was included as positive control. The results are representative of three independent experiments.